IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

GSK Inks Deal to Buy Stiefel for $3.6 billion

9:29 AM MDT | April 24, 2009 | DEEPTI RAMESH

GlaxoSmithKline (GSK) says it has signed an agreement to acquire dermatological product firm Stiefel Laboratories (Coral Gables, FL), for about $3.6 billion. The deal calls for GSK and Stiefel to combine their prescription dermatological products and operate the new global business under the Stiefel name within the GSK group. The transaction would create a specialty dermatology business with combined revenues of about $1.5 billion, GSK says. “As part of our strategy to grow and diversify GSK’s business, we are continuing to make new investments...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa